# Spry Therapeutics Inc. — Form D

Spry Therapeutics Inc. of MUMBAI, MAHARASHTRA, K7, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-19. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2024-11-19
- Form: D
- Accession: 0002044487-24-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 4
- Date of first sale: 2024-10-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-529788

## Issuer

- Name: Spry Therapeutics Inc.
- CIK: 0002044487
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 18 SANGAM B WING, FOUR BUNGLOWS, MUMBAI, MAHARASHTRA, K7, 400061
- Phone: (982) 057-8114

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Carl Venkatachalam Byers | Director | MUMBAI, MAHARASHTRA, K7 |
| Prem Venkatachalam Pavoor | Director | MUMBAI, MAHARASHTRA, K7 |
| Gupta Venkatachalam Shubham | Director | MUMBAI, MAHARASHTRA, K7 |

## More

- [CIK 2044487 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2044487&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002044487-24-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.